247 related articles for article (PubMed ID: 21238657)
41. Parenteral fish oil as monotherapy for patients with parenteral nutrition-associated liver disease.
de Meijer VE; Gura KM; Meisel JA; Le HD; Puder M
Pediatr Surg Int; 2009 Jan; 25(1):123-4. PubMed ID: 18828026
[No Abstract] [Full Text] [Related]
42. Is the use of parenteral omega-3 lipid emulsions justified in surgical neonates with mild parenteral nutrition-associated liver dysfunction?
Nasr A; Diamond IR; de Silva NT; Wales PW
J Pediatr Surg; 2010 May; 45(5):980-6. PubMed ID: 20438939
[TBL] [Abstract][Full Text] [Related]
43. Parenteral nutrition in the critically ill patient.
de Meijer VE; Gura KM; Puder M
N Engl J Med; 2010 Jan; 362(1):81-2; author reply 83-4. PubMed ID: 20058338
[No Abstract] [Full Text] [Related]
44. The use of fish oil lipid emulsion in the treatment of intestinal failure associated liver disease (IFALD).
Chang MI; Puder M; Gura KM
Nutrients; 2012 Nov; 4(12):1828-50. PubMed ID: 23363993
[TBL] [Abstract][Full Text] [Related]
45. [Use of fish oil lipid emulsions in hospitalized patients under 18 years old with abnormal results in liver tests associated with total parental nutrition].
Giraldo Villa A; Henao Roldan C; García Loboguerrero F; Martínez Volkmar MI; Contreras Ramírez MM; Ruiz Navas P;
Nutr Hosp; 2014 Apr; 29(4):844-51. PubMed ID: 24679026
[TBL] [Abstract][Full Text] [Related]
46. Relationship between biopsy-proven parenteralnutrition-associated liver fibrosis and biochemical cholestasis in children with short bowel syndrome.
Fitzgibbons SC; Jones BA; Hull MA; Zurakowski D; Duro D; Duggan C; Boctor D; Sigalet DL; Jaksic T
J Pediatr Surg; 2010 Jan; 45(1):95-9; discussion 99. PubMed ID: 20105587
[TBL] [Abstract][Full Text] [Related]
47. Enteral fish oil for treatment of parenteral nutrition-associated liver disease in six infants with short-bowel syndrome.
Tillman EM; Crill CM; Black DD; Hak EB; Lazar LF; Christensen ML; Huang EY; Helms RA
Pharmacotherapy; 2011 May; 31(5):503-9. PubMed ID: 21923431
[TBL] [Abstract][Full Text] [Related]
48. Refined Multidisciplinary Protocol-Based Approach to Short Bowel Syndrome Improves Outcomes.
Merras-Salmio L; Pakarinen MP
J Pediatr Gastroenterol Nutr; 2015 Jul; 61(1):24-9. PubMed ID: 25729889
[TBL] [Abstract][Full Text] [Related]
49. High rates of resolution of cholestasis in parenteral nutrition-associated liver disease with fish oil-based lipid emulsion monotherapy.
Premkumar MH; Carter BA; Hawthorne KM; King K; Abrams SA
J Pediatr; 2013 Apr; 162(4):793-798.e1. PubMed ID: 23164314
[TBL] [Abstract][Full Text] [Related]
50. [Fish oil in prolonged parenteral nutrition in children--omega-3-fatty acids have a beneficial effect on the liver].
Strijbosch RA; van den Hoonaard TL; Olieman JF; Escher JC; Alwayn IP; Meijers-Ijsselstijn H
Ned Tijdschr Geneeskd; 2010; 154():A2003. PubMed ID: 20977797
[TBL] [Abstract][Full Text] [Related]
51. Use of Fish Oil Intravenous Lipid Emulsions as Monotherapy in the Pediatric Intestinal Failure Patient: Beyond the Package Insert.
Gura KM; Calkins KL; Puder M
Nutr Clin Pract; 2020 Feb; 35(1):108-118. PubMed ID: 31549454
[TBL] [Abstract][Full Text] [Related]
52. Role of an intestinal rehabilitation program in the treatment of advanced intestinal failure.
Torres C; Sudan D; Vanderhoof J; Grant W; Botha J; Raynor S; Langnas A
J Pediatr Gastroenterol Nutr; 2007 Aug; 45(2):204-12. PubMed ID: 17667717
[TBL] [Abstract][Full Text] [Related]
53. Short-term intravenous fish oil and pediatric intestinal failure associated liver disease: 3-year follow-up on liver function and nutrition.
Calkins K; Lowe A; Shew SB; Dunn JC; Reyen L; Farmer DG; Devaskar SU; Venick R
J Pediatr Surg; 2013 Jan; 48(1):228-32. PubMed ID: 23331820
[TBL] [Abstract][Full Text] [Related]
54. Assessing portal fibrosis in parenteral nutrition-dependent patients treated with omega-3 fatty acid lipid emulsion.
Le HD; Gura KM; Arsenault DA; Fallon EM; Potemkin AK; Puder M
J Pediatr; 2010 Sep; 157(3):517; author reply 518. PubMed ID: 20584532
[No Abstract] [Full Text] [Related]
55. A review of enteral strategies in infant short bowel syndrome: evidence-based or NICU culture?
Miller M; Burjonrappa S
J Pediatr Surg; 2013 May; 48(5):1099-112. PubMed ID: 23701789
[TBL] [Abstract][Full Text] [Related]
56. Treatment of parenteral nutrition-associated liver disease: the role of lipid emulsions.
Nandivada P; Carlson SJ; Chang MI; Cowan E; Gura KM; Puder M
Adv Nutr; 2013 Nov; 4(6):711-7. PubMed ID: 24228202
[TBL] [Abstract][Full Text] [Related]
57. Intravenous Fish Oil and Pediatric Intestinal Failure-Associated Liver Disease: Changes in Plasma Phytosterols, Cytokines, and Bile Acids and Erythrocyte Fatty Acids.
Calkins KL; DeBarber A; Steiner RD; Flores MJ; Grogan TR; Henning SM; Reyen L; Venick RS
JPEN J Parenter Enteral Nutr; 2018 Mar; 42(3):633-641. PubMed ID: 28521607
[TBL] [Abstract][Full Text] [Related]
58. The experience of a regional pediatric intestinal failure program: Successful outcomes from intestinal rehabilitation.
Javid PJ; Malone FR; Reyes J; Healey PJ; Horslen SP
Am J Surg; 2010 May; 199(5):676-9. PubMed ID: 20466115
[TBL] [Abstract][Full Text] [Related]
59. Novel lipid-based approaches to pediatric intestinal failure-associated liver disease.
Diamond IR; Pencharz PB; Feldman BM; Ling SC; Moore AM; Wales PW
Arch Pediatr Adolesc Med; 2012 May; 166(5):473-8. PubMed ID: 22566549
[TBL] [Abstract][Full Text] [Related]
60. Role of parenteral lipid emulsions in the preterm infant.
Nandivada P; Carlson SJ; Cowan E; Chang MI; Gura KM; Puder M
Early Hum Dev; 2013 Oct; 89 Suppl 2():S45-9. PubMed ID: 23998451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
